文献速递功能神经外科

经皮三叉神经刺激治疗难治性面部疼痛:病例系列研究

Percutaneous Trigeminal Stimulation for Intractable Facial Pain: A Case Series.
PubMed 文献 · Neurosurgery · 2020-01-01

该回顾性病例系列纳入59例接受三叉神经节(TG)刺激的难治性面部疼痛患者,71.2%患者试验期成功;永久植入后约29.6%出现导线侵蚀、26.5%出现硬件感染、11.7%出现导线移位,疼痛数字评分平均降低2.49(95%CI 1.37-3.61;P=.0001),平均随访10.8个月。

要点

  • 59例难治性面部疼痛患者中,71.2%试验期刺激成功并接受永久植入。
  • 永久植入后导线侵蚀约29.6%、硬件感染约26.5%、导线移位11.7%。
  • 永久植入后平均10.8个月时疼痛数字评分降低2.49(95%CI 1.37-3.61;P=.0001)。

核心结论

  • TG刺激是治疗难治性面部疼痛可行的神经调控方法。
  • 面部/头部外伤和口腔手术可能预测试验刺激不成功。
  • 未来需要开发专门设计的三叉神经节刺激电极及减少导线污染的方案,以降低相对较高的并发症率。

研究设计与样本

  • 回顾性病历审查,纳入59例接受TG刺激的难治性面部疼痛患者,分析试验期和永久刺激后的结局。

主要发现

  • 71.2%的患者试验刺激成功。
  • 试验期发现1例TG导线侵蚀。
  • 与特发性病因疼痛相比,外伤史(面部/头部外伤和口腔手术)是试验失败的唯一预测因素(比值比:0.15;95%CI:0.03-0.66)。
  • 永久植入后,约29.6%和26.5%的患者分别被诊断为导线侵蚀和硬件感染。
  • 11.7%的患者发生TG导线移位。

关键数值与推荐

  • 试验刺激期间疼痛缓解>50%的患者接受永久植入刺激系统。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Facial pain syndromes can be refractory to medical management and often need neurosurgical interventions. Neuromodulation techniques, including percutaneous trigeminal ganglion (TG) stimulation, are reversible and have emerged as alternative treatment options for intractable facial pain. OBJECTIVE: To report the complication rates and analgesic effects associated with TG stimulation and identify potential predictors for these outcomes. METHODS: A retrospective chart review of 59 patients with refractory facial pain who underwent TG stimulation was conducted. Outcomes following trial period and permanent stimulation were analyzed. Patients with >50% pain relief during trial stimulation received permanent implantation of the stimulation system. RESULTS: Successful trial stimulation was endorsed by 71.2% of patients. During the trial period, 1 TG lead erosion was identified. History of trauma (facial/head trauma and oral surgery) was the only predictor of a failed trial compared to pain of idiopathic etiology (odds ratio: 0.15; 95% CI: 0.03-0.66). Following permanent implantation, approximately 29.6% and 26.5% of patients were diagnosed with lead erosion and infection of the hardware, respectively. TG lead migrations occurred in 11.7% of the patients. The numeric rating scale score showed a statistically significant reduction of 2.49 (95% CI: 1.37-3.61; P = .0001) at an average of 10.8 mo following permanent implantation. CONCLUSION: TG stimulation is a feasible neuromodulatory approach for the treatment of intractable facial pain. Facial/head trauma and oral surgery may predict a nonsuccessful trial stimulation. Future development of specifically designed electrodes for stimulation of the TG, and solutions to reduce lead contamination are needed to mitigate the relatively high complication rate.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Texakalidis P, Tora MS, McMahon JT, et al. Percutaneous Trigeminal Stimulation for Intractable Facial Pain: A Case Series. Neurosurgery. 2020. PMID: 32243534. doi:10.1093/neuros/nyaa065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。